The commercialisation toolkit for medtech inventors
“I want my research to help patients and result in real products or changes to practice... I applied for BridgeTech to gain the skills I need to commercialise my research and mentor others in my department to do the same.”
It takes a network to succeed in medtech commercialisation
"The program offered networking opportunities where I met clinicians and listened to a range of perspectives on unmet medical needs, which was invaluable.”
Translating novel research to a global medtech solution
“The BridgeTech Program helped me to better understand the business of translating research, which has directly informed my work on diagnostic technology development projects in my current role.”
“Mentorship is so important... It has been a privilege being pointed in the right direction by people of immense experience throughout my research journey and those I’ve connected with through the BridgeTech Program."
Each year 80 people from a diverse range of professions and institutions around Australia are selected to join the BridgeTech Program, delivered by QUT. Fully funded by MTPConnect and a consortium of industry and university partners, BridgeTech program participants join one of the country’s most significant medtech professional networks.
Our participants gain confidence, create networks and opportunities in all areas of medtech research commercialisation. You’ll learn through online modules, attend an inspiring seminar series, and network with top medtech companies and a nation-wide professional community.
The application round for our 2023 program has now closed. Thank you to all who applied. We’ll email you to let you know the outcome of your application in late February. If your application is successful, you’ll be invited to the program’s launch event to be held on March 15 in Brisbane.